Sciformix Furthers Global Expansion with Newly Strengthened Management Team

Company recognizes crucial roles that operations play as part of overall business strategy to ensure sustained success

28 April 2015, Boston, MA – Sciformix Corporation, a leading Scientific Process Organization (SPO), is pleased to announce the appointments of Warun Nayar as Chief Operations Officer (COO) and Abhay Joshi as Chief Finance Officer (CFO). These two new appointments, along with the announcement of David Balderson as Vice President Global Safety Operations in January reinforce Sciformix’s global business expansion and how they continue to invest to support their client’s needs and future growth.

As COO Warun Nayar will spearhead Sciformix’s delivery, practice management, HR, IT and administration functions. Warun brings a formidable body of experience and a proven ability to incentivize, synchronize and stabilize business operations. After a long tenure in the Army, his first corporate job was with Cambridge Technology Partners, where he went on to head the European operations. He spent 14 years at GE Capital International Services (GECIS) which was later rebranded as Genpact and held leadership positions vital in augmenting the growth story of the company. These included CIO for Genpact Europe, Operations Leader for Hungary and Kolkata sites, and then Business Leader for the Manufacturing, Telecom, Chemicals, Logistics, Media and Utilities verticals. His most recent role was Hitachi Operations Lead at Genpact Japan Business Services.

Abhay joins the Sciformix family as the CFO with over 25 years of experience in finance and accounts functions in technology, manufacturing and distribution sector companies worldwide. His areas of expertise include tax and legal compliance, cost management, budgeting and financial planning and MIS. He also has extensive experience in start-ups and managing their growth. Prior to joining Sciformix, Abhay was the finance head of the Enterprise Solutions business group at Tata Consultancy Services. During the course of his career he has worked with leading companies like Johnson & Johnson, IBM distributor company, Cummins and Symantec.

David Balderson, as Global VP of Safety Operations, has made great strides to further strengthen Sciformix’s delivery of global safety and pharmacovigilance (PV) solutions. David brings extensive knowledge and experience that will help enhance the company’s operational excellence, and global PV capabilities. Prior to joining Sciformix, David held senior leadership roles at Amgen US, first as Head of Global Safety Operations and then as Head of Global Regulatory Operations, and in Pharmacovigilance at GSK in the UK prior to that.

On the appointment of Warun, Manish Soman, President and CEO at Sciformix, commented, “He believes and lives by his values and attributes his success in setting up, investing and managing operations that build morale, employee empowerment and a positive culture in all his roles. He is recognized by his peers as a people leader and is a much sought after motivational speaker.”

He added of Abhay, “Abhay has consistently demonstrated success in implementing various systems for enhancing operational efficiency. He brings his proven analytical, negotiation and relationship management skills to Sciformix, which I am sure will prove to be pivotal.”

Sciformix’s long-term strategy focuses on evolving and enhancing our service and technology offerings, broadening our global reach and growing and diversifying the client and revenue base. The appointment of these leaders demonstrates Sciformix’s commitment and investment to support their expanding business.

To learn more about Sciformix visit www.sciformix.com , email us at ask@sciformix.com, or call us at +1.877.576.5005.

For further press information please contact: Scott Girling-Heathcote, The Scott Partnership: + 44 1477 539539 mail to sciformix@scottpr.com or Susan Najjar, Director of Marketing, Sciformix Corporation: + 1 617-264-0339 mail to susan.najjar@sciformix.com.

About Sciformix

Sciformix Corporation is a leading Scientific Process Organization (SPO), providing scientific knowledge-based services to pharmaceutical and biopharmaceutical, generics, consumer products, medical devices and other healthcare companies – in the areas of Safety and Risk Management, Clinical Research & Post-Approval Support and Regulatory Affairs.  Our mission is to partner with global life science companies to provide high quality scientific knowledge-based expertise to deliver better quality outcomes and improved efficiencies across the entire product lifecycle with the ultimate objective of improving quality of healthcare for patients worldwide. Corporate headquarters is located in Westborough, MA with operations in USA, UK, India and the Philippines.

We create value for our clients through our singular focus on the life sciences industry, strong pharmaceutical domain competency, exceptional subject matter expertise, industry reputed advisory board, uncompromising focus on quality, process rigor, predictable results, and ability to scale. Our portfolio of services spans the full spectrum of product lifecycle from pre-clinical and clinical to post marketing activities to help our customers solve complex analytical challenges, improve the quality of patient healthcare and increase client productivity.

Sciformix is dedicated to providing our clients outstanding services and solutions, fuelled by an unrivalled commitment to quality. We share the same level of involvement, dedication and passion as our clients and become an integral part of their team.  Our distinct combination of scientific expertise, process rigor and technology innovation delivers consistent, reliable and insightful results.  Our ability to scale and grow to meet your evolving needs means we are flexible and dedicated to your success in delivering safe products with more efficiency and greater speed. We help you make the right decisions at the right time by providing Trusted Services Built on Science.